• Study on Avelumab for Patients with Advanced or Metastatic Squamous Cell Penile Cancer After Initial Chemotherapy

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on Early Treatment of Plaque Psoriasis with Bimekizumab and Clobetasol Propionate for Patients with Chronic Inflammation

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study on Reducing Infections After Bladder Removal Surgery Using Pivmecillinam Hydrochloride and Other Antibiotics for Patients Undergoing Ureteral Stent Removal

    Recruiting

    3 1 1 1
    Investigated diseases:
    Denmark
  • Study on the Effectiveness of Gilteritinib and Drug Combination for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated diseases:
    Czechia Germany Italy Lithuania Portugal Romania +1
  • Study on Stopping Venetoclax and Azacitidine in Patients with Acute Myeloid Leukemia Who Are Responding to Treatment

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Ginisortamab with Nab-Paclitaxel and Gemcitabine or MEK Inhibitor for Patients with Metastatic Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Norway Spain
  • Study Comparing Effects and Safety of CT-P51 and Pembrolizumab with Drug Combination in Patients with Untreated Metastatic Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Croatia Greece Lithuania Poland Romania Spain
  • Study on Levothyroxine and Liothyronine for Patients with Autoimmune Hypothyroidism and Persistent Tiredness

    Recruiting

    3 1 1
    Investigated diseases:
    The Netherlands
  • Study on Lithium Carbonate for Patients with TBR1-Related Neurocognitive Disorder

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Effect of Esketamine and Sodium Chloride on Post-Craniotomy Headache in Patients with Drug-Resistant Temporal Lobe Epilepsy

    Recruiting

    3 1 1
    Investigated diseases:
    The Netherlands

powered by